| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.5M | -35.4% |
| Cost of Revenue | $6.5M | -10.7% |
| Gross Profit | -$2.0M | -606.4% |
| R&D Expense | $284K | +18.3% |
| SG&A Expense | $1.8M | +21.7% |
| Operating Income | -$4.6M | -66.8% |
| Interest Expense | $27K | -91.8% |
| Pre-tax Income | -$4.7M | -53.8% |
| Net Income | -$4.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $600K | -57.9% |
| Accounts Receivable | $232K | -54.0% |
| Inventory | $2.3M | -39.3% |
| Current Assets | $3.3M | -45.5% |
| Total Assets | $14.9M | -9.6% |
| Current Liabilities | $5.0M | -26.4% |
| Total Liabilities | $7.1M | -20.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$466K | +33.3% |
| Capital Expenditures | $38K | +233.5% |
| Investing Cash Flow | -$292K | -2432.9% |
| Financing Cash Flow | $27K | -62.6% |
| Free Cash Flow | -$505K | +29.0% |
| -53.8% |
| EPS (Basic) | -$0.27 | +70.3% |
| EPS (Diluted) | -$0.27 | +70.3% |
| Stockholders' Equity |
| $7.7M |
| +3.9% |